PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago SIG Group AG: Stable volumes, initial signs of growth recovery, progress on production footprint SIG Group AG reports stable volumes and initial signs of growth recovery in Q1 2024, with progress on production footprint. CEO expects volume growth acceleration throughout the year and improved profitability in the second half EBITDA Margin SIG Group AG Q1 2024 Volume Growth Production Footprint
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Branicks Group AG: Operationally successful in a challenging 2023 financial year Branicks Group AG reports operational success in challenging 2023 financial year, achieving targets with secured financing. Focus on new lettings and renewables asset class 2023 Financial Year Branicks Group AG Renewables Asset Class Operationally Successful Lettings
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago FUCHS with good start into financial year 2024 FUCHS SE reports a positive start to the financial year 2024 with a 4% increase in EBIT despite a 6% decrease in sales revenues. Acquisition of LUBCON Group signed EBIT Financial Year 2024 FUCHS SE Sales Revenues LUBCON Group
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Final allocation of DocMorris CHF 200 million Convertible Bonds Offering DocMorris AG finalizes the allocation of CHF 200 million Convertible Bonds Offering. Read more at the provided link Convertible Bonds Announcement CHF 200 Million DocMorris AG Allocation
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago ALSO finalises succession planning: Wolfgang Krainz appointed as new CEO ALSO Holding AG finalises succession planning with Wolfgang Krainz appointed as new CEO, succeeding Gustavo Moller-Hergt. More focus on sales aspects to accelerate sustainable growth Sales Growth CEO Appointment Succession Planning ALSO Holding AG Wolfgang Krainz
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Newron announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients Newron Pharmaceuticals S.p.A. announces positive Phase II/III study results of evenamide in schizophrenia patients, meeting primary and key secondary endpoints with good tolerability Schizophrenia Newron Pharmaceuticals Evenamide Phase II/III Study Glutamatergic Inhibition
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Baloise publishes financial condition report and discloses a healthy solvency ratio Baloise Holding AG has disclosed a healthy solvency ratio of 207% in its latest financial condition report, emphasizing strong capitalization Capitalization Baloise Holding AG Financial Condition Report Swiss Solvency Test Solvency Ratio
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report Xlife Sciences AG reports strong portfolio growth and strategic advances in the 2023 Valuation Report by independent consulting firm CYLAD Experts. Portfolio valued at CHF 611.7-747.8 million Portfolio Growth Xlife Sciences AG 2023 Valuation Report Strategic Advances CYLAD Experts
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Helvetia with continued strong solvency Helvetia reports an excellent SST ratio of 288% for the 2023 financial year, reaffirming its strong solvency and dividend ambition. The Group's balanced risk position supports its resilience Financial Position Helvetia SST Ratio Strong Solvency Dividend Ambition
PRESS RELEASE published on 04/30/2024 at 07:00, 2 years 6 months ago Straumann Group showed a solid start into 2024, with varied regional growth dynamic Straumann Group reports strong organic revenue growth of 15.1% in the first quarter of 2024, reaching CHF 643.8 million. Regional dynamics vary, with Asia Pacific leading. New premium implant system and intraoral scanner launched Revenue Growth Straumann Group First Quarter 2024 Premium Implant System Intraoral Scanner
Published on 11/06/2026 at 22:15, 19 hours 18 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 4 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 5 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 5 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 3 hours 58 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 21 hours 18 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 22 hours 17 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 22 hours 33 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 23 hours ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 23 hours 33 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 23 hours 38 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 23 hours 58 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026